Published in Gene Therapy Weekly, January 26th, 2006
This new funding will allow doctors and researchers at Lincoln-based Southeast Nebraska Cancer Center to develop new, more effective treatments for cancer patients based on their molecular profile. This funding is expected to be signed into law soon.
"This research will help us identify genomic sequence changes associated with cancer in individual patients," said Dr. Mark Carlson with the Southeast Nebraska Cancer Center.
"Our hope for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.